1. Home
  2. CPT vs DVA Comparison

CPT vs DVA Comparison

Compare CPT & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden Property Trust

CPT

Camden Property Trust

HOLD

Current Price

$103.50

Market Cap

10.4B

Sector

Real Estate

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$147.61

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPT
DVA
Founded
1993
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Misc Health and Biotechnology Services
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
10.0B
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
CPT
DVA
Price
$103.50
$147.61
Analyst Decision
Buy
Hold
Analyst Count
17
4
Target Price
$115.51
$156.75
AVG Volume (30 Days)
1.1M
613.2K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
4.23%
N/A
EPS Growth
136.00
N/A
EPS
3.54
9.84
Revenue
$12,967,000.00
$13,643,069,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
$2.66
$3.07
P/E Ratio
$28.27
$15.07
Revenue Growth
81.69
6.46
52 Week Low
$96.53
$101.00
52 Week High
$121.33
$159.42

Technical Indicators

Market Signals
Indicator
CPT
DVA
Relative Strength Index (RSI) 57.43 47.42
Support Level $101.09 $145.62
Resistance Level $106.47 $152.31
Average True Range (ATR) 1.95 3.82
MACD 0.60 -0.79
Stochastic Oscillator 98.12 36.96

Price Performance

Historical Comparison
CPT
DVA

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: